FDA Responds to Congressional Report on Toxic Heavy Metals in Baby Foods


In a recent blog post, we discussed the congressional report which found significant amounts of toxic heavy metals, including arsenic and lead, in many baby food products. In response to a justifiable outcry from concerned parents, advocacy groups, and members of Congress, the FDA has released its action plan for reducing babies’ and young children’s exposure to toxic elements. The FDA’s plan, Closer to Zero, is set to reduce exposure to toxic elements in foods commonly eaten by babies and young children to the lowest possible levels. The FDA’s four-stage approach is designed to cycle continual improvement through research, regulatory,…

Read More

Dangerous Practices at Chain Pharmacies Could Increase the Risk of Medication Error


Medication errors are unfortunate, potentially deadly incidents that affect over a million Americans annually. Medication errors are a subset of preventable medical errors, the estimated third leading cause of death in America. At pharmacies, medication errors most often occur when an incorrect medication or incorrect strength is given to a patient that does not align with their doctor’s prescription. Quickly misreading a prescription or medication label causes many of the medication errors that occur at pharmacies. Medication errors can occur at many levels within the prescription system (prescribing, transcribing, dispensing, administration, and monitoring) and pharmacists are one of the last…

Read More

Nootropics: How Safe Are They, Exactly?


In a competitive workforce and academic sphere, employees and students are more desperate than ever to gain an edge on the competition. Several believe that nootropics — drugs specifically designed to enhance cognitive function — represent that edge. Proponents claim that nootropics are highly beneficial and 100 percent safe, but a growing body of research suggests otherwise. Read on to learn more about these drugs — and why experts are sounding the alarm. Defining Nootropics Much of the danger surrounding nootropics lies in the struggle to define and classify these substances. Depending on whom you ask, nootropics could include dietary…

Read More

FDA WARNING: Qualaquin unapproved for use for night leg cramps due to serious side effects | DC Metro Area Medical Malpractice L


The FDA issued a warning this week due to continued reports of serious side effects in patients using Qualaquin “off-label” for night time leg cramps. This medication is not intended to be used to treat leg cramps, and the FDA has not approved it for this purpose. However, the majority of the use of Qualaquin in America is to relieve night time leg cramps instead of its approved use (to treat malaria caused by Plasmodiumfalciparum, which is rare). The use of Qualaquin can result in “serious and life-threatening blood-related (hematological) reactions” which in some cases may result in permanent kidney…

Read More

FDA WARNING: QUE SHE WEIGHT LOSS SUPPLEMENT CONTAINS DRUGS | DC Metro Area Medical Malpractice Law Blog


The FDA warned consumers and healthcare professionals today of the dangers of Que She, a capsule which was marketed as an herbal weight loss supplement but actually also “contains unlisted and active pharmaceutical ingredients that could harm consumers, especially those with cardiovascular conditions.” The FDA recommends that people who have purchased Que She should stop taking the product immediately and consult a health care professional. Below is an excerpt from the full FDA Public Health alert including the unlisted drugs within the “herbal supplement”: Que She, advertised as “Slimming Factor Capsule” and as “an all-natural blend of Chinese herbs,” has…

Read More